Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med. 2020;38(7):1549.e1543-1549.e1547.
Dinakaran D, Manjunatha N, Kumar CN, Suresh BM. Neuropsychiatric aspects of COVID-19 pandemic: a selective review. Asian J Psychiatr. 2020;53: 102188.
Article PubMed PubMed Central Google Scholar
Roy D, Ghosh R, Dubey S, Dubey MJ, Benito-León J, Ray BK. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2020. https://doi.org/10.1017/cjn.2020.173.
Article PubMed PubMed Central Google Scholar
Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of COVID-19: a review article. Neurol Sci. 2020;41:1667–71.
Article PubMed PubMed Central Google Scholar
Burdick KE, Millett CE. The impact of COVID-19 on cognition in severe cases highlights the need for comprehensive neuropsychological evaluations in all survivors. Neuropsychopharmacology. 2021. https://doi.org/10.1038/s41386-021-00995-7.
Article PubMed PubMed Central Google Scholar
Lucchese G, Flöel A. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons. Autoimmun Rev. 2020;19(7): 102556.
Article CAS PubMed PubMed Central Google Scholar
Natoli S, Oliveira V, Calabresi P, Maia LF, Pisani A. Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol. 2020;27(9):1764–73.
Article CAS PubMed PubMed Central Google Scholar
Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, Mazibuko N, Williams SC, Barnby JM, Hellyer P. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39: 101044.
Article PubMed PubMed Central Google Scholar
Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive impairment after COVID-19—a review on objective test data. Front Neurol. 2021. https://doi.org/10.3389/fneur.2021.699582.
Article PubMed PubMed Central Google Scholar
Woo MS, Malsy J, Pöttgen J, Seddiq Zai S, Ufer F, Hadjilaou A, Schmiedel S, Addo MM, Gerloff C, Heesen C. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2(2):fcaa05.
Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, Shi C, Hu S. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res. 2020;129:98–102.
Article PubMed PubMed Central Google Scholar
Miskowiak K, Johnsen S, Sattler S, Nielsen S, Kunalan K, Rungby J, Lapperre T, Porsberg C. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39–48.
Article CAS PubMed PubMed Central Google Scholar
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–32.
Article CAS PubMed PubMed Central Google Scholar
Fond G, Nemani K, Etchecopar-Etchart D, Loundou A, Goff DC, Lee SW, Lancon C, Auquier P, Baumstarck K, Llorca P-M. Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: a systematic review and meta-analysis. JAMA Psychiat. 2021;78(11):1208–17.
Roe K. The link between Toxoplasma gondii infections and higher mortality in COVID-19 patients having schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2021. https://doi.org/10.1007/s00406-021-01341-0.
Article PubMed PubMed Central Google Scholar
Kozloff N, Mulsant BH, Stergiopoulos V, Voineskos AN. The COVID-19 global pandemic: implications for people with schizophrenia and related disorders. Schizophr Bull. 2020;46(4):752–7.
Article PubMed PubMed Central Google Scholar
Bowie CR, Harvey PD. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat. 2006;2(4):531.
Article PubMed PubMed Central Google Scholar
Millan MJ, Agid Y, Brüne M, Bullmore ET, Carter CS, Clayton NS, Connor R, Davis S, Deakin B, DeRubeis RJ. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov. 2012;11(2):141–68.
Article CAS PubMed Google Scholar
MacKenzie NE, Kowalchuk C, Agarwal SM, Costa-Dookhan KA, Caravaggio F, Gerretsen P, Chintoh A, Remington GJ, Taylor VH, Müeller DJ. Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Front Psych. 2018;9:622.
Canal-Rivero M, Barragán RC, García AR, Torres NG, Crespo-Facorro B, Ruiz-Veguilla M, IBIS Translational Psychiatry Group. Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish population. Schizophr Res. 2021;229:53.
Article CAS PubMed PubMed Central Google Scholar
Haddad C, Salameh P, Hallit S, Obeid S, Haddad G, Clément J-P, Calvet B. Cross-cultural adaptation and validation of the Arabic version of the BACS scale (the brief assessment of cognition in schizophrenia) among chronic schizophrenic inpatients. BMC Psychiatry. 2021;21(1):1–12.
WHO. Clinical management of COVID-19: interim guidance. Geneva: WHO; 2020.
Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho B-C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiat. 2010;67(3):255–62.
Article CAS PubMed Google Scholar
Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46(12):1481–6.
Article CAS PubMed Google Scholar
Haddad C, Salameh P, Hallit S, Sacre H, Clément J-P, Calvet B. Self-assessment of social cognition in a sample of Lebanese in-patients with schizophrenia. Schizophr Res Cogn. 2021;26: 100207.
Article PubMed PubMed Central Google Scholar
Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004;68(2–3):283–97.
Hallit S, Obeid S, Haddad C, Kazour F, Kazour G. Validation of the Arabic Version of the PANSS scale among Lebanese schizophrenic patients. J Psychopathol. 2017.
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261.
Article CAS PubMed Google Scholar
Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry. 1993;163(S22):39–44.
Hani Y, Ghuloum S, Mahfoud Z, Opler M, Khan A, Yehya A, Abdulhakam A, Hammoudeh S, Al-Mujalli A, Elsherbiny R. Validation of the Arabic version of Calgary depression scale for schizophrenia. PLoS ONE. 2016;11(9): e0162304.
Article PubMed PubMed Central Google Scholar
Katz S. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–9.
Article CAS PubMed Google Scholar
Nasser R, Doumit J. Validity and reliability of the Arabic version of activities of daily living (ADL). BMC Geriatr. 2009;9(1):11.
Article PubMed PubMed Central Google Scholar
Kim H-Y. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 2013;38(1):52–4.
Article PubMed PubMed Central Google Scholar
Katan M, Moon YP, Paik MC, Sacco RL, Wright CB, Elkind MS. Infectious burden and cognitive function: the Northern Manhattan Study. Neurology. 2013;80(13):1209–15.
Article PubMed PubMed Central Google Scholar
Strandberg TE, Pitkala KH, Linnavuori KH, Tilvis RS. Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke. 2003;34(9):2126–31.
Tarter KD, Simanek AM, Dowd JB, Aiello AE. Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey. J Infect Dis. 2014;209(6):837–44.
Raper J, Kovacs-Balint Z, Mavigner M, Gumber S, Burke MW, Habib J, Mattingly C, Fair D, Earl E, Feczko E. Long-term alterations in brain and behavior after postnatal Zika virus infection in infant macaques. Nat Commun. 2020;11(1):1–12.
Steinfeld B, Scott J, Vilander G, Marx L, Quirk M, Lindberg J, Koerner K. The role of lean process improvement in implementation of evidence-based practices in behavioral health care. J Behav Health Serv Res. 2015;42(4):504–18.
留言 (0)